Search Results

The HYDRAGEL-MINI LIPO, HYDRAGEL LIPO, HYDRAGEL LIPO MAXI, HYDRAGEL, 7 LIPO, and HYDRAGEL 15/30 LIPO kits are designed for determination of lipoprotein profiles in human serum.

All HYDRAGEL LIPO kits utilize the same composition of alkaline buffered HYDRAGEL LIPO agarose gels, same reagents and the same procedure. The only differences among the individual kits are the number of samples per gel and that some kits are for the manual and some for the automated format:

The HYDRAGEL-MINI LIPO , HYDRAGEL LIPO and HYDRAGEL LIPO MAXI kits are designed for use with a manual electrophoresis apparatus. These kits are intended to run up to 5, 8 and 10 samples per gel, respectively.

The HYDRAGEL 7 LIPO and HYDRAGEL 15/30 LIPO kits are designed for use with the semiautomated Hydrasys electrophoresis apparatus. These kits are intended to run up to 7, 15 and 30 samples per gel, respectively,

The resulting electrophoregrams can be evaluated visually for pattern abnormalities or by densitometry to obtain approximate, relative quantification of individual zones. Fredrickson classification of lipoproteins aids in the interpretation of lipoprotein patterns. Indication of the qualitative (presence of abnormal or absence of normal fractions) or semi-quantitative (relative increase or decrease of fractions) abnormalities necessitates further lipoprotein analyses.

I am sorry, but based on the provided document, I cannot answer your request. The document is a 510(k) clearance letter for the HYDRAGEL LIPO Kits from the FDA in 1998. This type of document declares substantial equivalence to a predicate device but does not typically include detailed information about specific acceptance criteria or a comprehensive study report with the level of detail you are requesting, especially regarding AI algorithms, multi-reader multi-case studies, and ground truth establishment, which are more relevant to modern AI/ML medical device submissions.

The document mainly focuses on:

• The product names and their indications for use.
• Confirmation of substantial equivalence.
• Regulatory classifications and requirements.
• Contact information for various FDA offices.

There is no mention of acceptance criteria, device performance metrics, sample sizes for test or training sets, data provenance, expert ground truth establishment, adjudication methods, MRMC studies, standalone performance, or the ground truth types in the context of an AI/ML device. The device described appears to be a laboratory kit for manual or semi-automated electrophoresis, not an AI-powered diagnostic tool.

Ask a specific question about this device